Literature DB >> 20309842

Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II).

Jill Lobbestael1, Maartje Leurgans, Arnoud Arntz.   

Abstract

This study simultaneously assessed the inter-rater reliability of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders Axis I (SCID I) and Axis II disorders (SCID II) in a mixed sample of n = 151 inpatients and outpatients, and non-patient controls. Audiotaped interviews were assessed by independent second raters blind for the first raters' scores and diagnoses. Categorical inter-rater reliability was assessed for 12 Axis I disorders of SCID I, while both categorical and dimensional inter-rater reliability was tested for all Axis II disorders. Results revealed moderate to excellent inter-rater agreement of the Axis I disorders, while most categorically and dimensionally measured personality disorders showed excellent inter-rater agreement.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 20309842     DOI: 10.1002/cpp.693

Source DB:  PubMed          Journal:  Clin Psychol Psychother        ISSN: 1063-3995


  285 in total

1.  Test-retest reliability of the proposed DSM-5 eating disorder diagnostic criteria.

Authors:  Robyn Sysko; Christina A Roberto; Rachel D Barnes; Carlos M Grilo; Evelyn Attia; B Timothy Walsh
Journal:  Psychiatry Res       Date:  2012-03-06       Impact factor: 3.222

2.  Axis I psychopathology in bariatric surgery candidates with and without binge eating disorder: results of structured clinical interviews.

Authors:  LaShanda R Jones-Corneille; Thomas A Wadden; David B Sarwer; Lucy F Faulconbridge; Anthony N Fabricatore; Rebecca M Stack; Faith A Cottrell; Melissa E Pulcini; Victoria L Webb; Noel N Williams
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

3.  What constitutes clinically significant binge eating? Association between binge features and clinical validators in college-age women.

Authors:  Anna Vannucci; Kelly R Theim; Andrea E Kass; Mickey Trockel; Brooke Genkin; Marianne Rizk; Hannah Weisman; Jakki O Bailey; Meghan M Sinton; Vandana Aspen; Denise E Wilfley; C Barr Taylor
Journal:  Int J Eat Disord       Date:  2013-02-06       Impact factor: 4.861

4.  Predictors of treatment response to an adjunctive emotion regulation group therapy for deliberate self-harm among women with borderline personality disorder.

Authors:  Kim L Gratz; Katherine L Dixon-Gordon; Matthew T Tull
Journal:  Personal Disord       Date:  2014-01

5.  Patient learning of treatment contents in cognitive therapy.

Authors:  Nicole B Gumport; Lu Dong; Jason Y Lee; Allison G Harvey
Journal:  J Behav Ther Exp Psychiatry       Date:  2017-08-31

6.  The development and validation of the Memory Support Rating Scale.

Authors:  Jason Y Lee; Frank C Worrell; Allison G Harvey
Journal:  Psychol Assess       Date:  2015-09-21

7.  Patterns of Emotional Availability between Mothers and Young Children: Associations with Risk Factors for Borderline Personality Disorder.

Authors:  Rebecca D Trupe; Jenny Macfie; Rebecca M Skadberg; Gretchen Kurdziel
Journal:  Infant Child Dev       Date:  2017-06-21

8.  Ecological momentary assessment of stressful events and negative affect in bulimia nervosa.

Authors:  Andrea B Goldschmidt; Stephen A Wonderlich; Ross D Crosby; Scott G Engel; Jason M Lavender; Carol B Peterson; Scott J Crow; Li Cao; James E Mitchell
Journal:  J Consult Clin Psychol       Date:  2013-11-11

9.  Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: A randomized controlled trial.

Authors:  Edna B Foa; Anu Asnaani; David Rosenfield; Laurie J Zandberg; Peter Gariti; Patricia Imms
Journal:  J Consult Clin Psychol       Date:  2017-06-01

10.  Sleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosis.

Authors:  Jessica R Lunsford-Avery; Joseph M Orr; Tina Gupta; Andrea Pelletier-Baldelli; Derek J Dean; Ashley K Smith Watts; Jessica Bernard; Zachary B Millman; Vijay A Mittal
Journal:  Schizophr Res       Date:  2013-10-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.